clemastine and icatibant

clemastine has been researched along with icatibant in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bas, M; Bier, H; Greve, J; Hoffmann, TK; Kojda, G; Stark, T; Stelter, K1
Baş, M; Greve, J; Hapfelmeier, A; Havel, M; Hoffmann, TK; Kehl, V; Kojda, G; Rotter, N; Schossow, B; Stelter, K; Strassen, U; Veit, J1
Bas, M; Greve, J; Hoffmann, TK; Knopf, A; Strassen, U1

Trials

2 trial(s) available for clemastine and icatibant

ArticleYear
Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
    Annals of emergency medicine, 2010, Volume: 56, Issue:3

    Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Clemastine; Female; Humans; Injections, Subcutaneous; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome

2010
A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
    The New England journal of medicine, 2015, Jan-29, Volume: 372, Issue:5

    Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Bradykinin B2 Receptor Antagonists; Clemastine; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Histamine H1 Antagonists; Humans; Injections, Subcutaneous; Male; Middle Aged; Prednisolone; Time Factors

2015

Other Studies

1 other study(ies) available for clemastine and icatibant

ArticleYear
Treatment of angiotensin receptor blocker-induced angioedema: A case series.
    The Laryngoscope, 2015, Volume: 125, Issue:7

    Topics: Angioedema; Angiotensin Receptor Antagonists; Bradykinin; Bradykinin B2 Receptor Antagonists; Clemastine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Essential Hypertension; Female; Follow-Up Studies; Glucocorticoids; Histamine H1 Antagonists; Humans; Hypertension; Injections, Intravenous; Male; Prednisolone; Retrospective Studies; Treatment Outcome

2015